Bellevue Asset Management AG quarter change: USA Stocks, Added
In share positions in stocks (listed in the US), from the quarter ended 2015-09-30 to 2015-12-31, Bellevue Asset Management AG opened 4 positions, added to 25, reduced 12, sold out of 1 and left 27 unchanged. The largest increase in value was CAH (+$9,162,000); the largest decrease was THC (-$4,368,000).
- CAH: Country of operation United States; Class COM; Shares 2015-09-30 80,000; Shares 2015-12-31 171,480.
- CNC: Country of operation United States; Class COM; Shares 2015-09-30 20,000; Shares 2015-12-31 105,630.
- BIIB: Country of operation United States; Class COM; Shares 2015-09-30 71,770; Shares 2015-12-31 84,030.
- CVS: Country of operation United States; Class COM; Shares 2015-09-30 55,000; Shares 2015-12-31 96,200.
Two Form 13F-HR filings compared (SEC CIK 1642343): 2015-09-30 (filed 2015-11-12) and 2015-12-31 (filed 2016-02-12). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
| Stock | Country of operation | Class | Shares 2015-09-30 | Shares 2015-12-31 | Share change | Value 2015-09-30 | Value 2015-12-31 | Value change |
|---|
CAH
Cardinal Health, Inc. | United States | COM | 80,000 | 171,480 | +91,480 | $6,146,000 | $15,308,000 | +$9,162,000 |
|---|
CNC
Centene Corporation | United States | COM | 20,000 | 105,630 | +85,630 | $1,085,000 | $6,952,000 | +$5,867,000 |
|---|
BIIB
Biogen Inc. | United States | COM | 71,770 | 84,030 | +12,260 | $20,943,000 | $25,743,000 | +$4,800,000 |
|---|
CVS
CVS Health Corporation | United States | COM | 55,000 | 96,200 | +41,200 | $5,306,000 | $9,405,000 | +$4,099,000 |
|---|
BDX
Becton, Dickinson and Company | United States | COM | 92,305 | 105,075 | +12,770 | $12,245,000 | $16,191,000 | +$3,946,000 |
|---|
AMGN
Amgen Inc. | United States | COM | 120,000 | 123,000 | +3,000 | $16,598,000 | $19,967,000 | +$3,369,000 |
|---|
BAX
Baxter International Inc. | United States | COM | 50,000 | 110,000 | +60,000 | $1,643,000 | $4,197,000 | +$2,554,000 |
|---|
CYH
Community Health Systems, Inc. | United States | COM | 162,340 | 174,440 | +12,100 | $6,943,000 | $4,628,000 | -$2,315,000 |
|---|
HALO
Halozyme Therapeutics, Inc. | United States | COM | 246,000 | 318,000 | +72,000 | $3,304,000 | $5,511,000 | +$2,207,000 |
|---|
ILMN
Illumina, Inc. | United States | COM | 87,625 | 91,425 | +3,800 | $15,406,000 | $17,549,000 | +$2,143,000 |
|---|
BSX
Boston Scientific Corporation | United States | COM | 400,000 | 460,000 | +60,000 | $6,564,000 | $8,482,000 | +$1,918,000 |
|---|
ALKS
Alkermes Public Limited Company | | SHS | 59,000 | 65,500 | +6,500 | $3,462,000 | $5,199,000 | +$1,737,000 |
|---|
PRTA
Prothena Corporation plc | Ireland | SHS | 15,000 | 31,000 | +16,000 | $680,000 | $2,111,000 | +$1,431,000 |
|---|
CHRS
Coherus BioSciences, Inc | United States | COM | 230,000 | 257,000 | +27,000 | $4,609,000 | $5,901,000 | +$1,292,000 |
|---|
JAZZ
Jazz Pharmaceuticals Public Limited Company | | SHS USD | 56,000 | 60,000 | +4,000 | $7,437,000 | $8,434,000 | +$997,000 |
|---|
HCA
HCA Holdings, Inc. | United States | COM | 40,000 | 60,000 | +20,000 | $3,094,000 | $4,058,000 | +$964,000 |
|---|
COR
AmerisourceBergen Corporation | United States | COM | 60,000 | 64,000 | +4,000 | $5,699,000 | $6,637,000 | +$938,000 |
|---|
MCK
McKesson Corporation | United States | COM | 41,000 | 43,000 | +2,000 | $7,586,000 | $8,481,000 | +$895,000 |
|---|
PFE
Pfizer Inc. | United States | COM | 85,000 | 110,000 | +25,000 | $2,670,000 | $3,551,000 | +$881,000 |
|---|
EW
Edwards Lifesciences Corporation | United States | COM | 44,500 | 69,000 | +24,500 | $6,327,000 | $5,450,000 | -$877,000 |
|---|
SUPN
Supernus Pharmaceuticals, Inc. | United States | COM | 320,000 | 355,000 | +35,000 | $4,490,000 | $4,771,000 | +$281,000 |
|---|
INFIQ
Infinity Pharmaceuticals, Inc. | United States | COM | 130,000 | 160,000 | +30,000 | $1,099,000 | $1,256,000 | +$157,000 |
|---|
EXEL
Exelixis, Inc. | United States | COM | 150,000 | 170,000 | +20,000 | $842,000 | $959,000 | +$117,000 |
|---|
PRGO
Perrigo Company plc | Ireland | SHS | 40,000 | 44,000 | +4,000 | $6,291,000 | $6,367,000 | +$76,000 |
|---|
INCY
Incyte Corporation | United States | COM | 77,000 | 79,000 | +2,000 | $8,495,000 | $8,568,000 | +$73,000 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |